Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis
Conditions:   Primary Biliary Cirrhosis;   PBCInterventions:   Drug: LUM001;   Drug: Placebo;   Drug: Ursodeoxycholic AcidSponsor:   Lumena Pharmaceuticals, Inc.Active, not recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 17, 2013 Category: Research Source Type: clinical trials

Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis
Conditions:   Primary Biliary Cirrhosis;   PBCInterventions:   Drug: LUM001;   Drug: Placebo;   Drug: Ursodeoxycholic AcidSponsor:   ShireCompleted - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 17, 2013 Category: Research Source Type: clinical trials

Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis
Conditions:   Primary Biliary Cirrhosis;   PBCInterventions:   Drug: LUM001;   Drug: Placebo;   Drug: Ursodeoxycholic AcidSponsor:   Lumena Pharmaceuticals, Inc.Active, not recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 17, 2013 Category: Research Source Type: clinical trials

Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis
Conditions:   Primary Biliary Cirrhosis;   PBCInterventions:   Drug: LUM001;   Drug: Placebo;   Drug: Ursodeoxycholic AcidSponsor:   Lumena Pharmaceuticals, Inc.Active, not recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 17, 2013 Category: Research Source Type: clinical trials

Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis
Conditions:   Primary Biliary Cirrhosis;   PBCInterventions:   Drug: LUM001;   Drug: Placebo;   Drug: Ursodeoxycholic AcidSponsor:   Lumena Pharmaceuticals, Inc.Completed - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 17, 2013 Category: Research Source Type: clinical trials

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus
Condition:   Cholestasis, IntrahepaticInterventions:   Drug: GSK2330672;   Drug: Placebo;   Drug: Ursodeoxycholic acidSponsor:   GlaxoSmithKlineRecruiting - verified March 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2013 Category: Research Source Type: clinical trials